THOMAS JAMES DOYLE - 29 Jan 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Issuer symbol
KURA
Transactions as of
29 Jan 2024
Net transactions value
-$41,262
Form type
4
Filing time
31 Jan 2024, 17:30:18 UTC
Previous filing
04 Jan 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $10,573 -594 -1.2% $17.80 49,817 29 Jan 2024 Direct F1
transaction KURA Common Stock Sale $13,546 -761 -1.5% $17.80 49,056 29 Jan 2024 Direct F2
transaction KURA Common Stock Sale $17,142 -963 -2% $17.80 48,093 29 Jan 2024 Direct F3
holding KURA Common Stock 500 29 Jan 2024 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
F3 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.